Advanced search
Publication Cover
Pain Management Volume 2, 2012 - Issue 4
Submit an article Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Review

Cytokine-Related and Histological Biomarkers for Neuropathic Pain Assessment

Nurcan Üçeyler1 Department of Neurology, University of Würzburg, Josef-Schneider Str. 11, 97080Würzburg, Germany;1 Department of Neurology, University of Würzburg, Josef-Schneider Str. 11, 97080Würzburg, GermanyCorrespondence[email protected]
&
Claudia Sommer1 Department of Neurology, University of Würzburg, Josef-Schneider Str. 11, 97080Würzburg, Germany
Pages 391-398 | Published online: 02 Aug 2012

References

  • Treede RD , JensenTS, CampbellJN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18) , 1630–1635 (2008).
  • Haanpää M , AttalN, BackonjaM et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 152(1) , 14–27 (2011).
  • Klit H , FinnerupNB, JensenTS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol.8(9) , 857–868 (2009).
  • Bugnicourt JM , GarciaPY, CanapleS et al. Central neuropathic pain after cerebral venous thrombosis is not so uncommon: an observational study. J. Neurol. 258(6) , 1150–1156 (2011).
  • de Miguel M , KraycheteDC. Pain in patients with spinal cord injury: a review. Rev. Bras. Anestesiol.59(3) , 350–357 (2009).
  • Grau-Lopez L , SierraS, Martinez-CaceresE et al. Analysis of the pain in multiple sclerosis patients. Neurologia 26(4) , 208–213 (2011).
  • Hartemann A , AttalN, BouhassiraD et al. Painful diabetic neuropathy: diagnosis and management. Diabetes Metab. 37(5) , 377–388 (2011).
  • Manji H . Toxic neuropathy. Curr. Opin Neurol.24(5) , 484–490 (2011).
  • Üçeyler N , SommerC. Neuropathic pain assessment – an overview of existing guidelines and discussion points for the future. Eur. Neurolog. Rev.6(2) , 128–131 (2011).
  • Bouhassira D , AttalN, FermanianJ et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108(3) , 248–257 (2004).
  • Von Korff M , OrmelJ, KeefeFJ et al. Grading the severity of chronic pain. Pain 50(2) , 133–149 (1992).
  • Freynhagen R , BaronR, GockelU et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin 22(10) , 1911–1920 (2006).
  • Katsarava Z , YaldizliO, VoulkoudisC et al. Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV. J. Neurol. 253(12) , 1581–1584 (2006).
  • Obermann M , KatsaravaZ, EsserS et al. Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain 138(1) , 79–86 (2008).
  • Maihofner C , ForsterC, BirkleinF et al. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain 114(1–2) , 93–103 (2005).
  • Campbell JN , MeyerRA. Mechanisms of neuropathic pain. Neuron52(1) , 77–92 (2006).
  • Austin PJ , Moalem-TaylorG. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol.229(1–2) , 26–50 (2010).
  • Barnes PF , ChatterjeeD, BrennanPJ et al. Tumor necrosis factor production in patients with leprosy. Infect. Immun. 60(4) , 1441–1446 (1992).
  • Kaur I , AgnihotriN, MehtaM et al. Tumor necrosis factor (TNF) production in leprosy patients. Int. J. Lepr. Other Mycobact. Dis. 69(3) , 249–250 (2001).
  • Santos DO , SuffysPN, BonifacioK et al. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum. Clin. Immunol. Immunopathol.67(3 Pt 1) , 199–203 (1993).
  • Lasry-Levy E , HietaharjuA, PaiV et al. Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai. PLoS Negl. Trop. Dis. 5(3) , e981 (2011).
  • Gur A , KarakocM, ErdoganS et al. Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin. Exp. Rheumatol. 20(6) , 753–760 (2002).
  • Üçeyler N , ValenzaR, StockM et al. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 54(8) , 2656–2664 (2006).
  • Huygen FJ , De Bruijn AG, De Bruin MT et al. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm.11(1) , 47–51 (2002).
  • Ritz BW , AlexanderGM, NogusaS et al. Elevated blood levels of inflammatory monocytes (CD14+ CD16+) in patients with complex regional pain syndrome. Clin. Exp. Immunol. 164(1) , 108–117 (2011).
  • Alexander GM , PeterlinBL, PerreaultMJ et al. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J. Pain 13(1) , 10–20 (2011).
  • Brisby H , OlmarkerK, LarssonK et al. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur. Spine J. 11(1) , 62–66 (2002).
  • Burke JG , WatsonRW, McCormackD et al. Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc. Spine (Phila Pa 1976) 27(13) , 1402–1407 (2002).
  • Kotani N , KudoR, SakuraiY et al. Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am. J. Med. 116(5) , 318–324 (2004).
  • Zelenka M , SchafersM, SommerC. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain116(3) , 257–263 (2005).
  • Junger H , SorkinLS. Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain85(1–2) , 145–151 (2000).
  • Hao S , MataM, GloriosoJC et al. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol. Pain 2 , 6 (2006).
  • Milligan ED , SoderquistRG, MaloneSM et al. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol. 2(4) , 293–308 (2006).
  • Attal N , JazatF, KayserV et al. Further evidence for ‘pain-related‘ behaviours in a model of unilateral peripheral mononeuropathy. Pain 41(2) , 235–251 (1990).
  • Üçeyler N , TscharkeA, SommerC. Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav. Immun.21(5) , 553–560 (2007).
  • Sommer C , SchafersM, MarziniakM et al. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 6(2) , 67–72 (2001).
  • Gabay E , WolfG, ShavitY et al. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Eur. J. Pain 15(3) , 242–248 (2011).
  • Moreira AL , SampaioEP, ZmuidzinasA et al. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177(6) , 1675–1680 (1993).
  • Üçeyler N , GöbelK, MeuthSG et al. Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp. Neurol. 222(1) , 153–160 (2010).
  • Lantero A , TramullasM, DiazA et al. Transforming growth factor-beta in normal nociceptive processing and pathological pain models. Mol. Neurobiol. 45(1) , 76–86 (2011).
  • Üçeyler N , TopuzoğluT, SchiesserP et al. IL-4 Deficiency is associated with mechanical hypersensitivity in mice. PLoS One 6(12) , e28205 (2011).
  • Wallace DJ , MargolinK, WallerP. Fibromyalgia and interleukin-2 therapy for malignancy. Ann. Intern. Med.108(6) , 909 (1988).
  • Ladenstein R , PotschgerU, SiabalisD et al. Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion. J. Clin. Oncol. 29(4) , 441–448 (2011).
  • Liu KY , ChenYH, LiuDH et al. A pilot study of low-dose recombinant interleukin-2 for acute lymphoblastic malignancy after unmanipulated allogeneic blood and marrow transplantation. Bone Marrow Transplant. 42(8) , 535–539 (2008).
  • Watkins LR , MaierSF, GoehlerLE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain63(3) , 289–302 (1995).
  • Backonja MM , CoeCL, MullerDA et al. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J. Neuroimmunol. 195(1–2) , 157–163 (2008).
  • Ludwig J , BinderA, SteinmannJ et al. Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. J. Neurol. Neurosurg. Psychiatry 79(11) , 1268–1273 (2008).
  • Üçeyler N , RogauschJP, ToykaKV et al. Differential expression of cytokines in painful and painless neuropathies. Neurology 69(1) , 42–49 (2007).
  • Koike H , IijimaM, MoriK et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J. Neurol. Neurosurg. Psychiatry 79(10) , 1171–1179 (2008).
  • Wesseldijk F , HuygenFJ, Heijmans-AntonissenC et al. Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients. Eur. J. Pain 12(6) , 716–721 (2008).
  • Krämer HH , EberleT, ÜçeylerN et al. TNF-alpha in CRPS and ‘normal‘ trauma - significant differences between tissue and serum. Pain 152(2) , 285–290 (2011).
  • Schinkel C , ScherensA, KollerM et al. Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) – longitudinal investigations and differences to control groups. Eur. J. Med. Res. 14(3) , 130–135 (2009).
  • Üçeyler N , EberleT, RolkeR et al. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 132(1–2) , 195–205 (2007).
  • Alexander GM , van Rijn MA, van Hilten JJ et al. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain116(3) , 213–219 (2005).
  • Orlova IA , AlexanderGM, QureshiRA et al. MicroRNA modulation in complex regional pain syndrome. J. Transl. Med. 9 , 195 (2011).
  • Schwartzman RJ , ChevlenE, BengtsonK. Thalidomide has activity in treating complex regional pain syndrome. Arch. Intern. Med.163(12) , 1487–1488; author reply 1488 (2003).
  • Manning DC . Immunomodulatory agents for neuropathic pain syndromes: from animals to CRPS and beyond Eur. J. Pain (Suppl. 1) , S20 (2006).
  • Bernateck M , RolkeR, BirkleinF et al. Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1. Anesth. Analg. 105(4) , 1148–1151, table of contents (2007).
  • Huygen FJ , NiehofS, ZijlstraFJ et al. Successful treatment of CRPS 1 with anti-TNF. J. Pain Symptom Manage. 27(2) , 101–103 (2004).
  • Üçeyler N , KafkeW, RiedigerN et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74(22) , 1806–1813 (2010).
  • Üçeyler N , HeL, SchönfeldD et al. Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy. J. Peripher. Nerv. Syst. 16(4) , 304–314 (2011).
  • Lindenlaub T , SommerC. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol.105(6) , 593–602 (2003).
  • Empl M , RenaudS, ErneB et al. TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56(10) , 1371–1377 (2001).
  • Sommer C . Skin biopsy as a diagnostic tool. Curr. Opin Neurol.21(5) , 563–568 (2008).
  • Üçeyler N , RiedigerN, KafkeW et al. Genexpression von Zytokinen und neurotrophen Faktoren im N. suralis bei Patienten mit schmerzhafter und schmerzloser Polyneuropathie. Schmerz 22(Suppl. 2) , 165 (2008).
  • Petersen KL , RiceFL, FarhadiM et al. Natural history of cutaneous innervation following herpes zoster. Pain 150(1) , 75–82 (2010).
  • Pittenger GL , RayM, BurcusNI et al. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 27(8) , 1974–1979 (2004).
  • Üçeyler N , SchäfersM, SommerC. Mode of action of cytokines on nociceptive neurons. Exp. Brain Res.196(1) , 67–78 (2009).
  • Denda M , NakataniM, IkeyamaK et al. Epidermal keratinocytes as the forefront of the sensory system. Exp. Dermatol. 16(3) , 157–161 (2007).
  • Teles RM , AntunesSL, JardimMR et al. Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. J. Peripher. Nerv. Syst. 12(3) , 195–204 (2007).
  • Alexander GM , PerreaultMJ, ReichenbergerER et al. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav. Immun. 21(5) , 668–676 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.